In conjunction with the proposed asset purchase agreement, A123 has received a commitment from Johnson Controls for $72.5 million in debtor in possession financing to support A123’s continued operations during the pendency of the sale process.
http://www.a123systems.com
ABSMaterials, Inc. has been chosen for the 2012 Artemis Project Top 50 Water Tech Listing™ for the second year in a row. The Top 50 identifies the most promising companies that are applying inno- vation in the market to address today’s dire water challenges. The principal product of the company is Osorb®, a glass material that rapidly swells to pullsmall, organic toxins into its matrix. It repels water, making it ideal for water treatment. ABSMaterials is creating formulas to address various contaminants, including hydrocarbons, pharmaceuticals, pesticides, herbicides, chlorinated solvents and endocrine disruptors. Edmiston, a chemistry professor at the College of Wooster in Wooster, Ohio, USA, and inventor of Osorb®, became the company‘s chief scientist.
http://www.absmaterials.com
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced that the latest release of the company‘s enterprise electronic laboratory notebook (ELN), Symyx Notebook by Accelrys, offers a new multidimensional scientific spreadsheet for use in planning, executing and tracking a wide range of biological experiments. In addition, powerful new project tracking and optimization software provides a more complete biology solution, from efficient study orchestration to study execution in the lab.
Accelrys also reported financial results for the fiscal quarter ended September 30, 2012, including a 14% year-over-year increase in Non-GAAP revenue. Non-GAAP revenue for the quarter ended September 30, 2012 increased $5.4 million to $43.4 million from $38.0 million for the same quarter of the previous year, or an increase of 14%. Non-GAAP revenue for the nine months ended September 30, 2012, increased $12.6 million to $126.8 million from $114.1 million for the same period of the previous year, or an increase of 11%.
For the year ending December 31, 2012, the Company expects non-GAAP revenue to be between $169 and $171 million, and non-GAAP diluted earnings per share to be between $0.32 and $0.33 per diluted share on fully diluted weighted average shares outstanding of 56 million and using an effective tax rate of 40%.
http://www.accelrys.com
AMCOL International Corporation (NYSE: ACO) reports that the Board of Directors has declared a quarterly dividend of $0.20 per share, payable on October 9, 2012 to shareholders of record as of August 29, 2012. AMCOL also reports that it has filed a Form 12b-25 to report the delay in filing its Quarterly Report on Form 10-Q for the 2012 second quarter ended June 30, 2012. Following the release of AMCOL‘s earnings for the second quarter in a press release dated July 27, 2012, AMCOL determined that it may need to reduce the value of inventory recorded in its Environmental segment‘s operations in Spain. AMCOL management and their Audit Committee are working together to determine the amount of the reduction required and to identify the financial reporting periods impacted. At this time, the Company believes that the relevant periods may include one or more periods dating back to as early as 2010. Currently, neither AMCOL management nor their Audit Committee is able to determine whether any financial statements will need to be restated or whether the financial results presented in the July 27, 2012 press release will need to be revised.
http://www.amcol.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93